J Gynecol Oncol.  2017 May;28(3):e22. 10.3802/jgo.2017.28.e22.

Practice guidelines for management of cervical cancer in Korea: a Korean Society of Gynecologic Oncology Consensus Statement

Affiliations
  • 1Gynecologic Cancer Branch, Center for Uterine Cancer, and Center for Clinical Trials, Research Institute and Hospital and Cancer Control and Policy, Graduate School of Cancer Science and Policy, National Cancer Center, Goyang, Korea.
  • 2Department of Obstetrics and Gynecology, Seoul National University College of Medicine, Seoul, Korea.
  • 3Department of Obstetrics and Gynecology, Konkuk University School of Medicine, Seoul, Korea.
  • 4Department of Obstetrics and Gynecology, Yonsei University College of Medicine, Seoul, Korea.
  • 5Department of Preventive Medicine, College of Medicine, Korea University, Seoul, Korea.
  • 6Department of Obstetrics and Gynecology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
  • 7Department of Obstetrics and Gynecology, Gil Medical Center, Gachon University, Incheon, Korea.
  • 8Department of Obstetrics and Gynecology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea.
  • 9Department of Obstetrics and Gynecology, Ewha Womans University Mokdong Hospital, Ewha Womans University School of Medicine, Seoul, Korea.
  • 10Department of Obstetrics and Gynecology, Kyung Hee University Hospital at Gangdong, Kyung Hee University College of Medicine, Seoul, Korea. kgo02@hanmail.net
  • 11Department of Obstetrics and Gynecology, Pusan National University School of Medicine, Pusan, Korea.

Abstract

Clinical practice guidelines for gynecologic cancers have been developed by academic society from several countries. Each guideline reflected their own insurance system and unique medical environment, based on the published evidence. The Korean Society of Gynecologic Oncology (KSGO) published the first edition of practice guidelines for gynecologic cancer treatment in late 2006; the second edition was released in July 2010 as an evidence-based recommendation. The Guidelines Revision Committee was established in 2015 and decided to develop the third edition of the guidelines in an advanced format based on evidence-based medicine, embracing up-to-date clinical trials and qualified Korean data. These guidelines cover strategies for diagnosis and treatment of primary and recurrent cervical cancer. The committee members and many gynecologic oncologists derived key questions through discussions, and a number of relevant scientific literature were reviewed in advance. Recommendations for each specific question were developed by the consensus conference, and they are summarized here, along with the details. The objective of these practice guidelines is to establish standard policies on issues in clinical practice related to the management in cervical cancer based on the results in published papers to date and the consensus of experts as a KSGO Consensus Statement.

Keyword

Uterine Cervical Neoplasms; Practice Guideline; Consensus; General Surgery; Chemotherapy; Irradiation

MeSH Terms

Adenosarcoma/*diagnosis/*therapy
*Consensus
Female
Humans
Neoplasm Recurrence, Local/diagnosis/*therapy
Neoplasms, Glandular and Epithelial/*therapy
Republic of Korea
Societies, Medical
Uterine Cervical Neoplasms/*diagnosis/*therapy
Full Text Links
  • JGO
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr